...
首页> 外文期刊>Calcified tissue international. >The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
【24h】

The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.

机译:生长激素释放肽和脂联素与老年男性骨密度和骨转换指标的关系。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Body weight is commonly considered a significant predictor of bone mineral density (BMD). Adiponectin, an adipocyte-derived hormone, could modulate BMD. Moreover, recent studies have reported that ghrelin is able to stimulate bone formation. In this study, we investigated any associations of adiponectin and ghrelin serum levels with bone turnover markers and BMD in elderly men. In 137 men aged 55 years and older (mean age 67.4 +/- 5.4 years, mean body mass index [BMI] 26.6 +/- 3.4 kg/m2), we evaluated serum adiponectin, serum ghrelin, body composition (fat mass and lean mass), BMD, bone alkaline phosphatase (ALP), and the carboxy-terminal telopeptide of type I collagen (betaCTX). Ghrelin showed significant correlations with BMD at the femoral neck (r = 0.25, P < 0.01), total femur (r = 0.22, P < 0.05), and whole body (r = 0.18, P < 0.05). However, after adjusting for age, BMI, and calcium intake, the correlation remained significant only for femoral neck BMD. Ghrelin showed a significant correlation with lean mass but not with fat mass and bone turnover markers. Adiponectin showed a positive association with both bone ALP and betaCTX; the correlation between adiponectin and bone ALP (r = 0.25, P < 0.01) remained significant after adjusting for confounding variables. No significant correlations between adiponectin and BMD at all skeletal sites were observed. In conclusion, our study suggests that in elderly Italian men serum ghrelin was significantly associated with femoral neck BMD and that adiponectin was positively associated with bone ALP. Further studies are needed to elucidate the role of adipocytokines in bone metabolism.
机译:体重通常被认为是骨矿物质密度(BMD)的重要预测指标。脂联素(一种来自脂肪细胞的激素)可以调节BMD。此外,最近的研究报道了生长素释放肽能够刺激骨形成。在这项研究中,我们调查了脂联素和生长素释放肽血清水平与老年男性骨转换标志物和骨密度的任何相关性。在137位55岁及以上的男性(平均年龄67.4 +/- 5.4岁,平均体重指数[BMI] 26.6 +/- 3.4 kg / m2)中,我们评估了血清脂联素,血清生长素释放肽,身体成分(脂肪和瘦肉)质量,骨密度,骨碱性磷酸酶(ALP)和I型胶原的羧基末端端肽(betaCTX)。 Ghrelin与股骨颈的BMD(r = 0.25,P <0.01),股骨总数(r = 0.22,P <0.05)和整个身体(r = 0.18,P <0.05)显着相关。但是,在调整了年龄,BMI和钙摄入量之后,该相关性仅对于股骨颈BMD仍然显着。 Ghrelin显示与瘦肉量显着相关,但与脂肪量和骨转换指标无关。脂联素与骨ALP和betaCTX均呈正相关。调整混杂变量后,脂联素与骨ALP之间的相关性仍显着(r = 0.25,P <0.01)。在所有骨骼部位,脂联素和骨密度没有显着相关性。总之,我们的研究表明,在意大利老年男性中,血清生长素释放肽与股骨颈BMD显着相关,而脂联素与骨ALP呈正相关。需要进一步的研究来阐明脂肪细胞因子在骨代谢中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号